Skip to main content
. 2015 Feb 21;28(6):684–694. doi: 10.1007/s10278-015-9773-9

Table 3.

Mean, median and third quartile DAP values for CAG and PCI

Study No. of patients DAP or KAP (Gy cm2)
Mean Median Third quartile Range or upper limit
CAG Present study 2012 361 67.6 54.7 75.6 13.8 to 853.9
Sapinn et al. 2004 [19] 176 48.6 37 59.6 6.3 to 452.8
Van de Putte et al. 2000 [20] 62 60.64 56.82 80.58 144.23
Betsou et al. 1999 [21] 29 30.4
D’Helft et al. 2009 [22] 967 37.86 30.64 41.71 1.36 to 231.01
PCI Present study 2014 514 187 143 213 96 to 5220
Sapinn et al. 2004 [19] 70 153 103 189.5 18.8 to 655.0
Van de Putte et al. 2000 [20] 10 165.95 131.61 185.83 2.0 to 345.72
Betsou et al. 1999 [21] 7 70.7
D’Helft et al. 2009 [22] 463 78.3 58.05 83.56 47.5 to 410.38

DAP dose area product, CAG coronary angiography, PCI percutaneous transluminal coronary intervention